Influenza virus vaccine, h5n1 Disease Interactions
There are 4 disease interactions with influenza virus vaccine, h5n1.
Influenza vaccine (applies to influenza virus vaccine, h5n1) neurologic disorders
Major Potential Hazard, Moderate plausibility.
Influenza vaccine should be withheld, pending stabilization, in patients with active neurologic disorders associated with changing neurological status. Neurologic signs or symptoms following administration of an influenza vaccine is a contraindication to future use.
Influenza virus vaccine H5N1 (applies to influenza virus vaccine, h5n1) Guillain-Barre Syndrome (GBS)
Major Potential Hazard, Moderate plausibility.
Careful consideration of the potential risks and benefits should be given before deciding to give the influenza virus vaccine H5N1 to any patient who developed GBS within 6 weeks of receipt of a prior influenza vaccine.
Influenza virus vaccine H5N1 (applies to influenza virus vaccine, h5n1) hemophilia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Bleeding Associated with Coagulation Defect
As with other intramuscular injections, this vaccine should be given with caution in individuals with bleeding disorders, such as hemophilia or on anticoagulation therapy, to avoid the risk of hematoma following the injection.
Influenza virus vaccine H5N1 (applies to influenza virus vaccine, h5n1) immunodeficiency
Moderate Potential Hazard, Moderate plausibility.
If Influenza Virus Vaccine, H5N1, is administered to immunocompromised patients, including individuals receiving immunosuppressive therapy, the expected immune response may not be obtained.
Switch to professional interaction data
Influenza virus vaccine, h5n1 drug interactions
There are 298 drug interactions with influenza virus vaccine, h5n1.
Report options
More about influenza virus vaccine, h5n1
- influenza virus vaccine, h5n1 consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Tamiflu
Tamiflu is an antiviral medication used to treat flu symptoms caused by influenza. Learn about side ...
Xofluza
Xofluza (baloxavir marboxil) is used for the treatment and post-exposure prophylaxis of influenza ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Afluria
Afluria is a vaccine used to prevent infection caused by influenza virus. Learn about side effects ...
Fluad
Fluad (influenza vaccine) is used to prevent influenza. Includes Fluad side effects, interactions ...
Flucelvax Quadrivalent
Flucelvax Quadrivalent is an inactivated influenza virus vaccine used for the prevention of influenza.
Baloxavir marboxil
Baloxavir marboxil systemic is used for influenza, influenza prophylaxis
Influenza virus vaccine, inactivated
Influenza virus vaccine, inactivated systemic is used for influenza prophylaxis
Oseltamivir
Oseltamivir is an antiviral medication that blocks the actions of influenza virus types A and B ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.